Displaying drugs 451 - 475 of 12870 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Prolectin-M | Not Annotated |  | Prolectin-M is a (1-6)-alpha-D-mannopyranose and acts as an antagonist of galectin. It is being investigated in the clinical trial NCT04512027 (Prolectin-M in COVID-19 Patients Having Mild to Moderate Symptoms Not... | Not Annotated |
| iCo-007 | Not Available |  | Various eye diseases | Not Available |
| ATX-101 | Not Available |  | Investigated for use/treatment in solid tumors. | Not Available |
| XL999 | Not Available |  | Investigated for use/treatment in cancer/tumors (unspecified), lung cancer, and solid tumors. | Not Available |
| Ardeparin | Not Available |  | For prevention of deep vein thrombosis, which may result in pulmonary embolism, following knee surgery. | Anticoagulants |
| Semuloparin | Not Available |  | Investigated for use/treatment in thrombosis. | Anticoagulants / Carbohydrates / Cardiovascular Agents / Fibrin Modulating Agents / Glycosaminoglycans / Hematologic Agents / Heparin and similars / Polysaccharides |
| Ichthammol | Not Annotated |  | Ichthammol is also referred to as ammonium bituminosulfonate or ammonium bituminosulphonate. It is an ammonium salt of dark sulfonated shale oil (bituminous schists) produced via distillation of the oil followed... | Dermatologicals |
| Cholestyramine | Not Available |  | A bile acid sequestrant used as an adjunct in the reduction of elevated serum cholesterol in patients with primary hypercholesterolemia, and for the relief of pruritus associated with partial biliary obstruction. | Anion Exchange Resins / Anticholesteremic Agents / Bile Acid Sequestrants / Hypolipidemic Agents Indicated for Hyperlipidemia / Polystyrenes |
| PA-1050040 | Not Available |  | Investigated for use/treatment in HIV infection. | Not Available |
| Dextrose, unspecified form | Not Available |  | A form of glucose used for caloric supply and the replenishment of fluid in total parenteral nutrition and other therapies as well as for the treatment of hypoglycemic episodes. | Caloric Agents / Cardiac Function / Compounds used in a research, industrial, or household setting / Diabetes Mellitus / Hemodialysis Solution / Miscellaneous Therapeutic Agents / Sclerosing Solutions |
| YSIL6 | Not Available |  | Investigated for use/treatment in crohn's disease, psoriasis and psoriatic disorders, and rheumatoid arthritis. | Not Available |
| Sodium copper chlorophyllin | Not Annotated |  | Sodium copper chlorophyllin (SCC) is a water-soluble and bright green mixture derived from natural chlorophyll that has potential antimutagenic and antioxidant properties . This compound is used as a food... | Anti-Infective Agents, Local / Antimutagenic Agents / Radiation-Protective Agents |
| Sizofiran | Not Annotated |  | A beta-D-glucan obtained from the Aphyllophoral fungus Schizophyllum commune. It is used as an immunoadjuvant in the treatment of neoplasms, especially tumors found in the stomach. Sizofiran has been used... | Adjuvants, Immunologic / Antineoplastic Agents, Phytogenic / beta-Glucans |
| ENB-003 | Not Annotated |  | ENB-003 is a selective and potent inhibitor of the endothelin B receptor (ETBR) being investigated for cancer. | Not Annotated |
| ZEN-012 | Not Available |  | Investigated for use/treatment in cancer/tumors (unspecified). | Not Available |
| Invert sugar | Not Available |  | Invert sugar presents a large variety of uses. It can be used therapeutically for parenteral hyperalimentation or to be used as an excipient with a known effect. Invert sugar is... | Sclerosing Agents for Local Injection |
| Dihydroergocryptine | Not Annotated |  | A dopamine agonist indicated in the treatment of cerebrovascular diseases and atherosclerosis. | Dopamine Agonists |
| Ferric subsulfate | Not Annotated |  | Ferric subsulfate is a stypic or hemostatic agent that causes agglutination of surface proteins resulting in local hemostasis. It has the chemical formula Fe4(OH)2(SO4)5. It is used after superficial skin... | Hemostatics |
| Silica dimethyl silylate | Not Annotated |  | Not Annotated | Not Annotated |
| NRC-AN-019 | Not Annotated |  | Not Annotated | Antineoplastic Agents |
| Jaktinib | Not Annotated |  | Jaktinib is a JAK 1, JAK 2 and JAK 3 inhibitor, being developed by Suzhou Zelgen Biopharmaceuticals. Jaktinib is under investigation in clinical trial NCT04866056 (Jaktinib and Azacitidine in Treating... | Not Annotated |
| Pegsitacianine | Not Annotated |  | Pegsitacianine is under investigation in clinical trial NCT05576974 (A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection... | Not Annotated |
| EMZ702 | Not Available |  | Investigated for use/treatment in hepatitis (viral, C). | Not Available |
| SPG601 | Not Annotated |  | SPG601 is being investigated for the treatment of fragile X syndrome. | Not Annotated |
| QR-333 | Not Annotated |  | Investigated for use/treatment in neuropathy (diabetic). | Not Annotated |
Displaying drugs 451 - 475 of 12870 in total